Lilly Zyprexa IM "Approvable"; GMP Consultants Hired In Wake Of Inspections
Lilly believes Zyprexa IM is on track for a late summer launch following receipt of an "approvable" letter from FDA.
Lilly believes Zyprexa IM is on track for a late summer launch following receipt of an "approvable" letter from FDA.